Eriacta (sildenafil)
Eriacta is recorded as a 100 mg sildenafil tablet associated with Ranbaxy Laboratories.
- Active ingredient
- sildenafil
- Formulation
- Oral tablet
- Company in catalogue
- Ranbaxy Laboratories Ltd
Eriacta is recorded as a 100 mg sildenafil tablet associated with Ranbaxy Laboratories. Its separate name is retained even though Caverta is also attributed to Ranbaxy in the same source.
What distinguishes this product
A shared company and ingredient do not make two brands the same product record. For Eriacta, the useful comparison is the exact tablet, manufacturer or marketer shown on the pack, and the market-specific documentation. Do not substitute its source-listed 100 mg presentation for a differently prescribed strength.
Product record
- Record type
- Indian branded generic
- Treatment area in this directory
- Erectile dysfunction (ED)
- Active ingredient
- sildenafil
- Formulation in the cited record
- Oral tablet
- Source-listed strengths
- 100 mg
- Company in the cited record
- Ranbaxy Laboratories Ltd (Company attributed by the source catalogue)
- Manufacturing information
- A specific manufacturing site is not established by the cited catalogue record. Consult the country-specific label and pack.
- Market evidence
- Global reference; exact market authorization not established by this catalogue import
- Storage reported by source
- Store below 30°C Check the supplied leaflet for the exact presentation.
- Catalogue reviewed
Catalogue attributes describe the named product as reported by the source. Listed strengths are identification details, not dosing instructions. Ingredient evidence and company identity are useful signals; local product authorization is a separate question.
Ingredient references
These references cover the active ingredients. They do not verify every named brand, pack or formulation listed on this page.
How the ingredients fit treatment
Sildenafil supports the erection response to sexual stimulation by inhibiting PDE5. It is used before sexual activity in ED treatment; it is not a libido stimulant. Food can affect the response, so use the instructions for the prescribed presentation.
Ingredient guidance and safe use
Read the ingredient guidance alongside the leaflet for the actual product. A different brand, strength or dosage form may need different instructions.
Do not combine a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing. Tell the treating team which medicine you took and when.
Commonly reported effects of oral PDE5 medicines include headache, flushing, indigestion and nasal congestion; the pattern varies by ingredient and product. The cited ingredient information covers adverse effects and restrictions in more detail.
Interactions and urgent symptoms · Understanding formulations · Finding a local medicine record
Related product records
- Viagra — sildenafil
- Caverta — sildenafil
- Cenforce — sildenafil
- Cenforce Professional — sildenafil